Alastair Smith
Chief Executive Officer presso Avacta Life Sciences Ltd.
Patrimonio netto: 270 933 $ in data 31/03/2024
Profilo
Alastair MacLaughlin Smith is the founder of Avacta Group Plc, which was founded in 2004.
He held the title of Chief Executive Officer & Executive Director from 2005 to 2024.
Currently, Dr. Smith is the Chief Executive Officer & Director at Avacta Life Sciences Ltd.
and the Non-Executive Chairman at SPARTA Biodiscovery Ltd.
In the past, Dr. Smith worked as the Director-Institute of Molecular Biophysics at the University of Leeds and as a Director at TheraGenetics Ltd.Dr. Smith pursued his education at The University of Manchester, where he obtained both an undergraduate degree and a doctorate.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
AVACTA GROUP PLC
0.12% | 28/04/2023 | 431 100 ( 0.12% ) | 270 933 $ | 31/03/2024 |
Posizioni attive di Alastair Smith
| Società | Posizione | Inizio |
|---|---|---|
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom. | Chief Executive Officer | - |
Sparta Biodiscovery Ltd.
 Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology SPARTA Biodiscovery Ltd. manufactures instruments for chemical analysis and pharmaceutical research. The company is based in London, UK. The British company was founded by Molly M. Stevens. The CEO is Jelle Penders. | Chairman | - |
Precedenti posizioni note di Alastair Smith
| Società | Posizione | Fine |
|---|---|---|
| AVACTA GROUP PLC | Founder | 01/05/2024 |
TheraGenetics Ltd.
 TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Theragenetics Ltd. operates as a personalized medicine diagnostics company that develops and commercializes portfolio of pharmacogenetic diagnostic tests. The company was founded on March 13, 2006 and is headquartered in Wetherby, the United Kingdom. | Director/Board Member | - |
| University of Leeds | Corporate Officer/Principal | - |
Formazione di Alastair Smith
| The University of Manchester | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AVACTA GROUP PLC | Commercial Services |
| Aziende private | 3 |
|---|---|
TheraGenetics Ltd.
TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Theragenetics Ltd. operates as a personalized medicine diagnostics company that develops and commercializes portfolio of pharmacogenetic diagnostic tests. The company was founded on March 13, 2006 and is headquartered in Wetherby, the United Kingdom. | Health Technology |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom. | Health Technology |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology SPARTA Biodiscovery Ltd. manufactures instruments for chemical analysis and pharmaceutical research. The company is based in London, UK. The British company was founded by Molly M. Stevens. The CEO is Jelle Penders. | Health Technology |
- Borsa valori
- Insiders
- Alastair Smith
